Key Takeaways Regarding Operationalizing Bispecific Antibodies for MM
Panelists summarize key takeaways on using bispecific antibodies for multiple myeloma treatment.
Stay updated with breaking news from Combination Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Panelists summarize key takeaways on using bispecific antibodies for multiple myeloma treatment.
Biotech firm Moderna has good news for humanity. The company is preparing for its post-Covid vaccine, which will be more effective than the previous jabs.
Focusing on mantle cell lymphoma, Lori A. Leslie, MD, reviews the primary analysis of the SYMPATICO trial investigating ibrutinib-venetoclax combination therapy.
BROOKLINE, Mass.--(BUSINESS WIRE)--Mar 25, 2024--
The panel reviews axatilimab, an emerging agent for chronic GVHD under clinical studies. The experts explore findings from the Agave-201 study, highlighting potential challenges of intravenous administration and axatilimab’s unique mechanisms.